New England Journal of Medicine· 2012Q1· Review
Diabetic Retinopathy
- 1,600citations
- Q1SCImago
- 2012year
Short summary
Despite rising diabetes rates, diabetic retinopathy incidence is declining, likely due to improved management of glucose, lipids, and blood pressure.
AI-generated from the title and abstract; the full text is not read.
Key points
- Diabetic retinopathy incidence is falling despite increasing diabetes rates.
- Improved management of glucose, lipids, and hypertension is the probable cause.
- Clinical trials of VEGF and PPAR-α inhibitors are yielding positive results for vision and pathogenesis insights.
AI-generated from the title and abstract; the full text is not read.
Abstract
The incidence of diabetes is increasing, but that of diabetic retinopathy is falling, probably owing to better management of glucose levels, lipid abnormalities, and hypertension. Clinical trials of VEGF and PPAR-α inhibitors are improving vision and providing insights into pathogenesis.
The authors' abstract, as published at the source. New England Journal of Medicine, 2012 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Ophthalmology
OphthalmologyMedicine